[Study & clinical trial of R 1625 or haloperidol, a new neuroleptic & so-called neurodysleptic agent].
D014150:Antipsychotic Agents; D004565:Electroconvulsive Therapy; D006220:Haloperidol; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D001523:Mental Disorders; D011612:Psychosurgery; D011613:Psychotherapy; D011618:Psychotic Disorders / Q000628:therapy*
D014150:Antipsychotic Agents; D006993:Hypnotics and Sedatives; D006220:Haloperidol
HYPNOTICS AND SEDATIVES/therapeutic use; INSANITY; PSYCHOSES/therapy
Etude et expérimentation cliniques du R 1625 ou halopéridol, nouveau neuroleptique et neurodysleptique.